Cargando…
Design and Characterization of Novel Antibody-Cytokine Fusion Proteins Based on Interleukin-21
Interleukin-21 (IL21) is a pleiotropic cytokine involved in the modulation of both innate and adaptive immunity. IL21 is mainly secreted by natural killer (NK) and activated CD4+ T-cells. The biology of this cytokine can be associated to proinflammatory responses reflecting its potent stimulatory ac...
Autores principales: | Di Nitto, Cesare, Neri, Dario, Weiss, Tobias, Weller, Michael, De Luca, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944420/ https://www.ncbi.nlm.nih.gov/pubmed/35323193 http://dx.doi.org/10.3390/antib11010019 |
Ejemplares similares
-
An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties
por: Di Nitto, Cesare, et al.
Publicado: (2023) -
An Antibody Targeting Fibroblast Activation Protein Simultaneously Fused to Interleukin-2 and Tumor Necrosis Factor Selectively Localizes to Neoplastic Lesions
por: Prodi, Eleonora, et al.
Publicado: (2023) -
Generation and in vivo validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibody
por: Nadal, Lisa, et al.
Publicado: (2022) -
Design and characterisation of a novel interleukin-15 receptor alpha fusion protein and analysis of interleukin-15 complexation
por: Schmid, Anja Sophie, et al.
Publicado: (2019) -
Novel human monoclonal antibodies specific to the alternatively spliced domain D of Tenascin C efficiently target tumors in vivo
por: Nadal, Lisa, et al.
Publicado: (2020)